Phase 4 would be the end game, bringing total production to 65,000 kilograms per year, or over four times the amount the company will have when Phase 2 finishes. That comes with a huge caveat, however; if the company’s planned expansions hit their expected targets, then we’re looking at a whole different company. Generously apply broad spectrum SPF 30+ sunscreen every 2 hours, even on cloudy days, and after swimming or sweating. At the same time, some are more undervalued than others, and in my view, Organigram doesn’t quite have enough going in its favor to make it especially more attractive than other options.

And more importantly, what does the Organigram stock forecast look like? Is the company undervalued? Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock.
OrganiGram last posted its quarterly earnings results on July 21st, 2020. Savvy investors should strongly consider putting these 5G stocks on their watchlist. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The OGI stock price has dropped by about three percent since the beginning of 2018, but that’s not too concerning when you factor in that February has been a rough go for many marijuana companies. Find the latest Earnings Report Date for Organigram Holdings Inc. Common Shares (OGI) at Nasdaq.com. Organigram Hlds Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. OGI OrganiGram Holdings, Inc. 242.22% upside potential. Long. A UV index reading of 0 to 2 means low danger from the sun's UV rays for the average person. The lighter blue line represents the stock's consensus price target. Stephen Karmazyn, BA CryptoTrend-Alerts Follow Following Unfollow. NV5 Global Inc: Why This Stock Could Surge in COVID-19 Recovery, Health Catalyst Inc: Why This May Be the Perfect Healthcare Stock Regardless of Election. Terms of Service | Privacy Policy. OrganiGram Holdings Inc. analyst estimates by MarketWatch. The firm earned $22.24 million during the quarter, compared to the consensus estimate of $20.83 million. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Learn more. OGI stock was purchased by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Swiss National Bank, WFA of San Diego LLC, WFA of San Diego LLC, Goldman Sachs Group Inc., XTX Markets LLC, and TD Asset Management Inc..